Form 8-K - Current report:
SEC Accession No. 0001564590-21-005146
Filing Date
2021-02-10
Accepted
2021-02-10 09:04:38
Documents
14
Period of Report
2021-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-8k_20210209.htm   iXBRL 8-K 47337
2 EX-99.1 d132458dex991.htm EX-99.1 6834
3 GRAPHIC g132458logo.jpg GRAPHIC 1132151
  Complete submission text file 0001564590-21-005146.txt   1752453

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210209.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210209_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210209_pre.xml EX-101.PRE 12078
7 EXTRACTED XBRL INSTANCE DOCUMENT sybx-8k_20210209_htm.xml XML 3642
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 21609499
SIC: 2834 Pharmaceutical Preparations